CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,359,736
- in 11 filings, $2.4M under 10b5-1 plans
Net −$2,359,736. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-23 | NASH DAVID Director | Grant or award | +6,865 | 38,561 | ||
| 2022-04-27 | NASH DAVID Director | Grant or award | +10,049 | 31,696 | ||
| 2021-03-23 | NASH DAVID Director | Grant or award | +9,292 | 21,647 | ||
| 2020-04-10 | NASH DAVID Director | Grant or award | +7,119 | 12,355 | ||
| 2019-05-24 | NASH DAVID Director | Purchase | +1,445 | $68.76 | $99K | 5,236 |
| 2019-03-28 | NASH DAVID Director | Grant or award | +1,991 | 3,791 | ||
| 2019-03-28 | NASH DAVID Director | Grant or award · Stock Options | +2,409 | 2,409 | ||
| 2018-06-06 | NASH DAVID Director | Grant or award | +1,800 | 1,800 | ||
| 2018-06-06 | NASH DAVID Director | Grant or award · Stock Options | +2,225 | 2,225 |
Page 1 of 1 · 9 trades